Triglyceride-glucose index variability and incident cardiovascular disease : a prospective cohort study
© 2022. The Author(s)..
BACKGROUND: Recent studies have suggested that triglyceride-glucose (TyG) index is an independent predictor of cardiovascular disease (CVD). However, the impact of long-term visit-to-visit variability in TyG index on the risk of CVD is not known. We aimed to investigate the longitudinal association between baseline and mean TyG index as well as TyG index variability and incident CVD in a Chinese population.
METHODS: We included 49,579 participants without previous history of CVD in the Kailuan study who underwent three health examinations (2006, 2008, and 2010) and were followed up for clinical events until 2019. TyG index was calculated as Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. We measured TyG index variability as the SD of the residuals obtained from a linear regression on the three TyG index measurements for each individual. Multivariate-adjusted Cox models were used to estimate the adjusted hazard ratio (aHR) and 95% confidence interval (CI) with incident CVD.
RESULTS: During a median follow-up time of 9.0 years, 2404 developed CVD. The highest tertile (T3) of baseline and mean TyG index were each associated with higher CVD incidence as compared with the lowest tertile (T1): aHR, 1.25; 95% CI 1.11-1.42; and aHR 1.40; 95% CI 1.24-1.58, respectively. Tertile 3 of TyG index variability was associated with increased CVD incidence compared to T1 group (aHR, 1.12; 95% CI 1.01-1.24). Similar findings were observed in a series of sensitivity analyses.
CONCLUSION: Higher TyG index level and greater TyGindex variability were each independently associated with a higher incidence of CVD.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
---|---|
Enthalten in: |
Cardiovascular diabetology - 21(2022), 1 vom: 10. Juni, Seite 105 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Li, Haibin [VerfasserIn] |
---|
Links: |
---|
Themen: |
Biomarkers |
---|
Anmerkungen: |
Date Completed 14.06.2022 Date Revised 27.08.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1186/s12933-022-01541-5 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM342108905 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM342108905 | ||
003 | DE-627 | ||
005 | 20231226013328.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1186/s12933-022-01541-5 |2 doi | |
028 | 5 | 2 | |a pubmed24n1140.xml |
035 | |a (DE-627)NLM342108905 | ||
035 | |a (NLM)35689232 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Li, Haibin |e verfasserin |4 aut | |
245 | 1 | 0 | |a Triglyceride-glucose index variability and incident cardiovascular disease |b a prospective cohort study |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 14.06.2022 | ||
500 | |a Date Revised 27.08.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a BACKGROUND: Recent studies have suggested that triglyceride-glucose (TyG) index is an independent predictor of cardiovascular disease (CVD). However, the impact of long-term visit-to-visit variability in TyG index on the risk of CVD is not known. We aimed to investigate the longitudinal association between baseline and mean TyG index as well as TyG index variability and incident CVD in a Chinese population | ||
520 | |a METHODS: We included 49,579 participants without previous history of CVD in the Kailuan study who underwent three health examinations (2006, 2008, and 2010) and were followed up for clinical events until 2019. TyG index was calculated as Ln [fasting triglyceride (mg/dL) × fasting glucose (mg/dL)/2]. We measured TyG index variability as the SD of the residuals obtained from a linear regression on the three TyG index measurements for each individual. Multivariate-adjusted Cox models were used to estimate the adjusted hazard ratio (aHR) and 95% confidence interval (CI) with incident CVD | ||
520 | |a RESULTS: During a median follow-up time of 9.0 years, 2404 developed CVD. The highest tertile (T3) of baseline and mean TyG index were each associated with higher CVD incidence as compared with the lowest tertile (T1): aHR, 1.25; 95% CI 1.11-1.42; and aHR 1.40; 95% CI 1.24-1.58, respectively. Tertile 3 of TyG index variability was associated with increased CVD incidence compared to T1 group (aHR, 1.12; 95% CI 1.01-1.24). Similar findings were observed in a series of sensitivity analyses | ||
520 | |a CONCLUSION: Higher TyG index level and greater TyGindex variability were each independently associated with a higher incidence of CVD | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Cardiovascular disease | |
650 | 4 | |a Cohort study | |
650 | 4 | |a Triglyceride-glucose index | |
650 | 4 | |a Variability | |
650 | 7 | |a Biomarkers |2 NLM | |
650 | 7 | |a Blood Glucose |2 NLM | |
650 | 7 | |a Triglycerides |2 NLM | |
650 | 7 | |a Glucose |2 NLM | |
650 | 7 | |a IY9XDZ35W2 |2 NLM | |
700 | 1 | |a Zuo, Yingting |e verfasserin |4 aut | |
700 | 1 | |a Qian, Frank |e verfasserin |4 aut | |
700 | 1 | |a Chen, Shuohua |e verfasserin |4 aut | |
700 | 1 | |a Tian, Xue |e verfasserin |4 aut | |
700 | 1 | |a Wang, Penglian |e verfasserin |4 aut | |
700 | 1 | |a Li, Xia |e verfasserin |4 aut | |
700 | 1 | |a Guo, Xiuhua |e verfasserin |4 aut | |
700 | 1 | |a Wu, Shouling |e verfasserin |4 aut | |
700 | 1 | |a Wang, Anxin |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cardiovascular diabetology |d 2002 |g 21(2022), 1 vom: 10. Juni, Seite 105 |w (DE-627)NLM119878380 |x 1475-2840 |7 nnns |
773 | 1 | 8 | |g volume:21 |g year:2022 |g number:1 |g day:10 |g month:06 |g pages:105 |
856 | 4 | 0 | |u http://dx.doi.org/10.1186/s12933-022-01541-5 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 21 |j 2022 |e 1 |b 10 |c 06 |h 105 |